A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines.
Jena KK, Qu P, Baracco L, Saghaei S, Keerti, Allahyari Z, Boehmer D, Mitchell M, Dillen CA, Li HY, Liu E, Poli V, Dufies O, Hoytema van Konijnenburg DP, Spreafico R, Bi C, Hall R, Kruppa MD, Ma Z, Gravitte A, Lowman DW, Ensley HE, Marty P, Boyer L, Collomp R, Williams DL, Ma VP, Lee PY, Nigrovic PA, Karp JM, Elledge SJ, Wesemann DR, Wu Y, Frieman M, Zanoni I.
Jena KK, et al.
Nat Immunol. 2026 Jun;27(6):1130-1144. doi: 10.1038/s41590-026-02517-3. Epub 2026 May 22.
Nat Immunol. 2026.
PMID: 42174265
Free PMC article.